Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroprevalence of Anti-bodies Against Clostridium Difficile Toxins and Prevalence of Asymptomatic Carriage of Clostridium Difficile in IBD Patients.

NCT03889808 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT03889808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03889808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroprevalence of Anti-bodies Against Clostridium Difficile Toxins and Prevalence of Asymptomatic Carriage of Clostridium Difficile in IBD Patients.
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2014
Completion date
December 31, 2021
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile, inflammatory bowel diseases